John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

While the song’s backstory might be staged on its cover - a recreation of the moment Harry Houdini was supposedly passed a ...

Analysts led by Edward Yang said Camtek is most lauded for high-resolution 3D inspection tools that boost AI chip yields by ...

DoorDash (NASDAQ:DASH) is on the path to reach $4.5B in EBITDA in 2027, thanks to increased spending on advertising and the ...

“Yeah…it’s interesting what he stayed away from,” Cameron, 70, told Deadline of Nolan, 54, when asked if he was surprised Oppenheimer won seven Oscars and grossed nearly $1 billion. “Look, I love the ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

This Best Picture Oscar winner sailed past $2 billion at the global box office, and it’s not Oppenheimer or Forrest Gump!

The teaser, which is 70 seconds long, briefly shows Matt Damon’s lead character Odysseus, his son Telemachus (played by Tom ...

James Cameron addressed Christopher Nolan's Oppenheimer, saying that the film was a 'moral cop out' due to a lack of certain ...

Filmmaker James Cameron has a critique of fellow director Christopher Nolan’s award-winning film, Oppenheimer.

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.

Sure, the film echoes actual testimony and captures Oppenheimer ’s inner collapse with chilling precision. But it also leans into spectacle, trimming inconvenient truths and dramatizing quiet tensions ...